On cough syrups, a long overdue prescription, Pg10

Key Highlights:

• The Centre removed cough syrups from Schedule K of the Drugs Rules, 1945, mandating a prescription for their sale.
• This decision applies to all syrup-based medicines, including those containing opioids like codeine.
• The move follows the deaths of over 20 children in Madhya Pradesh and Rajasthan in October 2023 due to contaminated cough syrups.
• Indian-made cough syrups have been linked to over 140 child deaths in Africa and Central Asia since 2022.
• Contaminated products, such as Coldrif, were found to contain excessive diethylene glycol.

Detailed Insights:

• Previously, Schedule K, Entry 13, exempted certain cough syrups from prescription requirements, leading to weaker regulatory oversight.
• This exemption fostered a culture of self-medication and fragmented accountability across the drug supply chain.
• Vulnerable communities, particularly in rural areas, were disproportionately affected by the unregulated sale of these medicines.
• The new prescription mandate necessitates rigorous enforcement, enhanced transparency in reporting adverse events, and increased investment in rural healthcare.
• India's drug regulation framework suffers from a Centre-state coordination deficit and loopholes in quality control and inspection.
• The regulatory change aims to prioritize patient safety over reactive crisis management in the pharmaceutical sector.

Key Concepts Involved:

• Schedule K: A part of the Drugs Rules, 1945 that lists medicines exempt from certain provisions, allowing non-prescription sale.
• Drugs Rules, 1945: Regulations framed under the Drugs and Cosmetics Act, 1940, governing drug manufacturing, sale, and distribution in India.
• Diethylene glycol: A toxic industrial solvent that, when present as a contaminant in medicines, can cause severe kidney damage and death.
• Self-medication: The practice of individuals taking medicines on their own initiative without consulting a medical professional.